Supriya Mohile shared the following on X:
“Dr. Zhihong Zhang (Sandy) reports that only 18 percent of vulnerable older adults with advanced cancer receiving chemotherapy had symptomatic improvements (resilient symptom trajectory using PRO-CTCAE). Risk often > benefit.”
